The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants
Open accessAbstract
Purpose To evaluate the long-term efficacy of ciliary neurotrophic factor delivered via an intraocular encapsulated cell implant for the treatment of retinitis pigmentosa.Design Long-term follow-up of a multicenter, sham-controlled study.Methods Thirty-six patients at 3 CNTF4 sites were randomly assigned to receive a high- or low-dose implant in 1 eye and sham surgery in the fellow eye. The primary endpoint (change in visual field sensitivity at 12 months) had been reported previously. Here we measure long-term visual acuity, visual field, and optical coherence tomography (OCT) outcomes in 24 patients either retaining or explanting the device at 24 months relative to sham-treated eyes.Results Eyes retaining the implant showed significantly greater visual field loss from baseline than either explanted eyes or sham eyes through 42 months. By 60 months and continuing through 96 months, visual field loss was comparable among sham-treated eyes, eyes retaining the implant, and explanted eyes, as was visual acuity and OCT macular volume.Conclusions Over the short term, ciliary neurotrophic factor released continuously from an intravitreal implant led to loss of total visual field sensitivity that was greater than the natural progression in the sham-treated eye. This additional loss of sensitivity related to the active implant was reversible when the implant was removed. Over the long term (60-96 months), there was no evidence of efficacy for visual acuity, visual field sensitivity, or OCT measures of retinal structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuroprotective factors that support the survival of retinal cells, such as glial cell-derived neurotrophic factor (GDNF), ciliary neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor, and pigment epithelium-derived factor (PEDF) have shown promise in mouse models of retinal degeneration.67,103–105”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LaVail, M. M., Unoki, K., Yasumura, D., Matthes, M. T., Yancopoulos, G. D., & Steinberg, R. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11249 · Cited by 722
Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor
Faktorovich, E. G., Steinberg, R. H., Yasumura, D., Matthes, M. T., & LaVail, M. M. (1990) · Nature · doi:10.1038/347083a0 · Cited by 710
A computerized method of visual acuity testing
Beck, R. W., Moke, P. S., Turpin, A. H., Ferris, F. L., SanGiovanni, J. P., Johnson, C. A., Birch, E. E., Chandler, D. L., Cox, T. A., Blair, R. C., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01825-1 · Cited by 613
Sieving, P. A., Caruso, R. C., Tao, W., Coleman, H. R., Thompson, D. J. S., Fullmer, K. R., & Bush, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600236103 · Cited by 591
Tao, W., Wen, R., Goddard, M. B., Sherman, S., O'Rourke, P., Stabila, P. F., Bell, W. J., Dean, B. J., Kauper, K., Budz, V. A., et al. (2002) · PubMed · Cited by 325
Talcott, K. E., Ratnam, K., Sundquist, S. M., Lucero, A. S., Lujan, B. J., Tao, W., Porco, T. C., Roorda, A., & Duncan, J. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6479 · Cited by 276
Self-citationWahlin, K. J., Campochiaro, P. A., Zack, D. J., & Adler, R. (2000) · PubMed · Cited by 256
Stahl, N., & Yancopouloš, G. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251111 · Cited by 254
Cayouette, M., Behn, D., Sendtner, M., Lachapelle, P., & Gravel, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-22-09282.1998 · Cited by 230
Cayouette, M., & Gravel, C. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.4-423 · Cited by 223
Cited by
Sorted by citations
Non-syndromic retinitis pigmentosa
Verbakel, S. K., van Huet, R. A. C., Boon, C. J. F., den Hollander, A. I., Collin, R. W. J., Klaver, C. C. W., Hoyng, C. B., Roepman, R., & Klevering, B. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.03.005 · Cited by 973
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., Silva‐Cunha, A., Woo, S. J., & Kwon, Y. J. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 437
Athanasiou, D., Aguilà, M., Bellingham, J., Li, W., McCulley, C. H., Reeves, P. J., & Cheetham, M. E. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.002 · Cited by 379
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
Duncan, J., Pierce, E., Laster, A., Daiger, S. P., Birch, D., Ash, J., Iannaccone, A., Flannery, J., Sahel, J., Zack, D., et al. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.4.6 · Cited by 228
Self-citationBucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Metadata
- Authors
- Birch, D. G., Bennett, L. D., Duncan, J. L., Weleber, R. G., & Pennesi, M. E.
- Affiliations
- Retina Foundation of the Southwest (US)
- University of California, San Francisco (US)
- Oregon Health & Science University (US)
- Corresponding author
- Birch, David G.
- Venue
- American Journal of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 170
- Pages
- 10-14
- ISSN
- 0002-9394 (ISSN-L)
- PMC
- PMC5056139
- OpenAlex
- W2501579558
- Cited by
- 112
- References
- 22
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 4 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 19 · 2017: 8 · 2016: 1
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (5k08ey021186-03)
- U.S. Food and Drug Administration (R01 FD004100)
- National Eye Institute (R01EY009076, K08-EY021186)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- retinitis pigmentosa, ciliary neurotrophic factor, visual field sensitivity, visual acuity, macular volume, implant removal, long-term efficacy, neurotrophic therapy
- MeSH terms
- Adult, Aged, Electroretinography, Female, Follow-Up Studies, Humans, Male, Retina, Retinitis Pigmentosa, Visual Acuity, Visual Fields, Drug Delivery Systems, Ciliary Neurotrophic Factor, Tomography, Optical Coherence, Visual Field Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
